发明授权
- 专利标题： Hydrazide compounds and thrombopoietin receptor activators
- 专利标题（中）： 酰肼化合物和血小板生成素受体激活剂
-
申请号： US12092834申请日： 2006-11-07
-
公开(公告)号： US08026368B2公开(公告)日： 2011-09-27
- 发明人: Katsuaki Miyaji , Yukihiro Shigeta , Satoshi Nakano , Hirofumi Ota , Norihisa Ishiwata
- 申请人： Katsuaki Miyaji , Yukihiro Shigeta , Satoshi Nakano , Hirofumi Ota , Norihisa Ishiwata
- 申请人地址： JP Tokyo
- 专利权人： Nissan Chemical Industries, Ltd.
- 当前专利权人： Nissan Chemical Industries, Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- 优先权： JP2005-322114 20051107
- 国际申请： PCT/JP2006/322193 WO 20061107
- 国际公布： WO2007/052808 WO 20070510
- 主分类号： C07D401/00
- IPC分类号： C07D401/00 ; A61K31/44
摘要：
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.A compound represented by the formula (I) (wherein R1, R2, R3, L1, L2, X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
公开/授权文献
- US20090253751A1 HYDRAZIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR 公开/授权日：2009-10-08